Author(s): Shirin A. Mazumder | Anna Hicks | John Norwood
Journal: North American Journal of Medical Sciences
ISSN 1947-2714
Volume: 2;
Issue: 4;
Start page: 205;
Date: 2010;
VIEW PDF
DOWNLOAD PDF 
Original page
Keywords: Nontuberculous mycobacteria | rifampin | cure | contaminant
ABSTRACT
Context: Nontuberculous mycobacteria are non-communicable organisms and currently there are over 125 species. Nontuberculous mycobacteria are usually recovered from the environment and can cause disease through respiratory, cutaneous, parenteral and gastrointestinal exposure. Case Report: We describe a case of a young, immunocompetent patient that developed symptomatic Mycobacterium gordonae pulmonary infection. A computed tomography of the chest revealed hilar lymphadenopathy and nodular densities on the left side. Definitive diagnosis was made by a culture of a transbronchial biopsy. Treatment consisted of a short course of rifampin and ethambutol, which resulted in a clinical and radiographic improvement. Conclusions: Mycobacterium gordonae is capable of causing clinically significant disease in both immunocompetent and immunosuppressed individuals.
Journal: North American Journal of Medical Sciences
ISSN 1947-2714
Volume: 2;
Issue: 4;
Start page: 205;
Date: 2010;
VIEW PDF
DOWNLOAD PDF Original pageKeywords: Nontuberculous mycobacteria | rifampin | cure | contaminant
ABSTRACT
Context: Nontuberculous mycobacteria are non-communicable organisms and currently there are over 125 species. Nontuberculous mycobacteria are usually recovered from the environment and can cause disease through respiratory, cutaneous, parenteral and gastrointestinal exposure. Case Report: We describe a case of a young, immunocompetent patient that developed symptomatic Mycobacterium gordonae pulmonary infection. A computed tomography of the chest revealed hilar lymphadenopathy and nodular densities on the left side. Definitive diagnosis was made by a culture of a transbronchial biopsy. Treatment consisted of a short course of rifampin and ethambutol, which resulted in a clinical and radiographic improvement. Conclusions: Mycobacterium gordonae is capable of causing clinically significant disease in both immunocompetent and immunosuppressed individuals.
